Abstraction Health

Melatonin

Hormone

Also known as: N-acetyl-5-methoxytryptamine

🟡Moderate Evidence 216 expert mentions 20 studies
C·58/100·Fair
Research Depth25/25
Study Quality9/25
Expert Consensus23/25
Claim Support1/25
How we score the evidence →

A pineal hormone that regulates circadian rhythm and sleep timing. Most experts recommend much lower doses (0.1–0.5mg) than typical OTC products (5–10mg). Best evidence for jet lag and circadian phase shifts.

Common forms:immediate releaseextended release

The bottom line

Melatonin is best understood as a circadian-timing signal, not a sleeping pill — its most legitimate uses are jet lag and shifting your body clock, and even Huberman and Tracey Marks (both tracked here) urge caution about routine use. The broad sleep claims outrun the evidence. Two practical points: a low dose (0.5–3 mg) is usually all that's needed, and product dose-accuracy is notoriously poor, so a third-party-tested product matters (see the sourcing checklist). Avoid in pregnancy and in children without medical guidance.

Our plain-language reading of the expert claims and research on this page. Not medical advice.

How expert claims hold up

216 of 216 claims assessed
6Supported3Partial207Insufficient

9 of 216 assessed claims supported or partially supported by published research

Expert Consensus

Broad consensusResearch agrees
4/5
Experts mention
3
Recommend
2
Flag caution
Tracey Marks
Tracey Marks Recommends Caution
Research agrees114 claims5-10milligrams or 10milligrams or 0.5-1milligram or 0.1-0.3milligrams
Andrew Huberman
Andrew Huberman Recommends Caution
Research agrees90 claims5–10milligrams or 0.5milligrams or 0.3milligrams or 0.1–0.5milligrams or 0.1–0.3milligramsgummytablet
David Sinclair
David Sinclair Recommends
Research agrees2 claims
Mark Hyman
Research agrees10 claims

Dose divergence: Experts recommend different amounts (5-10milligrams, 10milligrams, 0.5-1milligram, 0.1-0.3milligrams, 5–10milligrams, 0.5milligrams, 0.3milligrams, 0.1–0.5milligrams, 0.1–0.3milligrams). Check the Stack & Timing tab for study-backed dosing ranges.

Evidence Summary

PubMed / NCBI·May 2026
All 20 studies
20
Studies
3
RCTs
12
Reviews

The available research on melatonin paints a consistent picture of it as a hormone with well-characterized biological roles, though the evidence base for many specific health claims remains limited or indirect. Across multiple reviews and meta-analyses, melatonin is reliably described as a chronobiotic agent — a darkness-signaling hormone produced by the pineal gland — rather than a sedative or sleeping pill. This mechanistic characterization is one of the most consistently supported findings in the literature reviewed. Beyond its role in circadian regulation, melatonin has been studied in contexts ranging from fertility and ICU care to cardiovascular health and traumatic brain injury, suggesting broad biological relevance, though the strength of evidence varies considerably across these applications. The strongest evidence clusters around melatonin's role in sleep quality improvement and its use in ICU settings, supported by systematic reviews and meta-analyses, which represent the highest tier of study design. A meta-analysis on dietary supplements and sleep quality found melatonin among the agents with measurable effects on sleep outcomes. Separately, a systematic review and meta-analysis on ICU use provides moderate-to-strong support for melatonin's application in that specialized population. Reviews touching on fertility, PCOS, and antioxidant supplementation mention melatonin as a candidate intervention, but findings in these areas are more preliminary and less conclusive. The majority of expert-level claims evaluated — 199 out of 214 — were rated as having insufficient evidence, which underscores how much of the popular discourse around melatonin outpaces the current science. Several important caveats limit confidence in the broader evidence base. Most studies reviewed are narrative or general reviews rather than large, high-quality RCTs with melatonin as the primary intervention. Populations studied are often not clearly defined, making it difficult to generalize findings. Pediatric use is a particular area of concern: one review specifically addresses pharmacotherapy in children with neurodevelopmental disorders, and the available literature supports caution rather than routine use in this group, citing limited long-term safety data. Dosing, timing, and formulation vary widely across studies, and long-term effects of supplementation remain poorly characterized. The gap between what is scientifically established and what is widely claimed about melatonin is substantial.

Read full evidence summary →

Top studies

Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis.

Advances in nutrition (Bethesda, Md.) · 2024 · Shang Y et al.
Meta-Analysis🟢
Key finding

Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis.

PMID: 39019217DOI: 10.1016/j.advnut.2024.100273
View on PubMed

Antioxidants for female subfertility.

The Cochrane database of systematic reviews · 2020 · Showell MG et al.
Meta-Analysis🟢
Key finding

Antioxidants for female subfertility.

COI: Roger Hart is the Medical Director of Fertility Specialists of WA and a shareholder in Western IVF. He has received educational sponsorship from Merck Serono and Ferring pharmaceuticals, and is on the medical advisory board of MSD and Ferring Pharmaceuticals. Rebecca Mackenzie‐Proctor: no conflict of interest to declare. Vanessa Jordan: no conflict of interest to declare. Marian Showell: no conflict of interest to declare
PMID: 32851663DOI: 10.1002/14651858.CD007807.pub4
View on PubMed

Expert Mentions

All 216 mentions
Tracey Marks
Tracey Marks
Tracey Marks MD
Caution / warning

Some animal studies suggest it may affect pubertal timing, though this hasn't been demonstrated in humans definitively.

Extracted claim

Some animal studies suggest melatonin supplementation may affect pubertal timing, though this has not been definitively demonstrated in humans.

Insufficient evidence to assessHigh confidence

None of the 10 provided studies directly address the claim that melatonin supplementation may affect pubertal timing in animals or humans. The retrieved literature covers topics such as sleep quality,…

Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Caution / warning

I'm particularly cautious about melatonin in children and teenagers. There's limited long-term safety data, and melatonin plays developmental roles that we don't fully understand.

Extracted claim

Huberman is particularly cautious about melatonin use in children and teenagers due to limited long-term safety data and melatonin's developmental roles that are not fully understood.

Insufficient evidence to assessHigh confidence

None of the 10 provided studies directly address melatonin safety in children or adolescents, or melatonin's developmental roles. The retrieved literature covers topics such as melatonin in ICU patien…

Safety, interactions & who should avoid Melatonin

generally_recognized_safe

Melatonin is generally described as well-tolerated in short-term adult use across the reviewed literature, but long-term safety data are limited and caution is specifically warranted in children and adolescents due to melatonin's hormonal nature and insufficient pediatric safety evidence.

Melatonin is generally considered safe for short-term use in adults, but long-term effects remain understudied. High OTC doses (5–10 mg) far exceed physiological levels and may desensitize melatonin receptors over time. Pediatric use should occur only under medical supervision at the lowest effective dose for the shortest necessary duration. Users should always disclose melatonin use to their healthcare provider, particularly given potential interactions with medications.

Who should avoid it

Individuals who are pregnant or breastfeeding should use caution due to insufficient safety data. Those with autoimmune conditions should consult a physician given melatonin's immunomodulatory activity. Children and adolescents should only use melatonin under medical guidance. People with bleeding disorders or taking anticoagulants should exercise caution.

Known interactions

  • ·Anticoagulants (e.g., warfarin) — melatonin may enhance anticoagulant effects
  • ·CNS depressants and sedatives — additive sedation risk
  • ·Immunosuppressants — melatonin has immunomodulatory properties that may interfere
  • ·Antidiabetic medications — melatonin may affect insulin sensitivity and glucose regulation
  • ·Hormonal contraceptives — may alter melatonin metabolism or endogenous levels

Pregnancy & breastfeeding

Our sources specifically flag pregnancy or breastfeeding considerations for Melatonin — see the cautions above.

We don’t assign pregnancy-safety ratings. Many supplements lack adequate safety data in pregnancy and breastfeeding, and the absence of a warning here does not mean a supplement is safe to take. Don’t start, stop, or continue any supplement while pregnant or nursing without your OB-GYN or midwife.

Read: Supplements during pregnancy & breastfeeding →

This is educational information only. Consult a healthcare provider before starting any supplement.

Stay on top of Melatonin research

One email a month when new research on Melatonin is published.

Double opt-in · unsubscribe anytime · not medical advice.

Sourcing matters for Melatonin

The poster child for dose-accuracy failure — independent testing found products ranging from a fraction to several times the labeled dose, with some containing serotonin.

What to check before you buy

  • Third-party tested for actual content vs. label (USP Verified is the gold standard)
  • Tested to be free of serotonin and other contaminants
  • A low dose available (0.5–3 mg; many products overdose at 5–10 mg)
  • Exact mg labeled — no proprietary "sleep blend" hiding the melatonin amount

This is about product quality — separate from the evidence grade above, which scores the research. Our sourcing standards →

Sources

No buy link — yet

We only link products that meet our sourcing standards — use the checklist above if you’re shopping on your own. We haven’t linked one for Melatonin yet. Our standards →

Key findings

  • ·Melatonin is consistently characterized across multiple reviews as a chronobiotic hormone — a darkness signal produced by the pineal gland — not a sedative or sleep drug.
  • ·A meta-analysis on dietary supplements found melatonin associated with improvements in sleep quality outcomes, representing one of the stronger evidence-based applications.
  • ·A systematic review and meta-analysis supports melatonin use in ICU patients, suggesting potential benefits in this specific clinical population.

Evidence gaps

  • ·Long-term safety and efficacy data for melatonin supplementation in healthy adults and children are largely absent from the reviewed literature, leaving many dosing and duration questions unanswered.
  • ·Most reviewed studies are narrative reviews or general overviews rather than large, well-controlled RCTs, making it difficult to establish causality or optimal dosing protocols for specific conditions.
  • ·Evidence for melatonin in specialized areas such as fertility, PCOS, cardiovascular health, and traumatic brain injury is indirect or preliminary, based on reviews that include melatonin among many interventions rather than dedicated melatonin trials.